文献速递糖尿病肥胖与代谢综合征

AMPK亚基基因变异对体脂、糖代谢和胆固醇代谢的遗传决定因素 largely 不重叠

AMPK Subunits Harbor Largely Nonoverlapping Genetic Determinants for Body Fat Mass, Glucose Metabolism, and Cholesterol Metabolism.
PubMed 文献 · J Clin Endocrinol Metab · 2020-01-01

该研究在2789名非糖尿病参与者中分析AMPK全部7个亚基基因的常见SNP与肥胖、胰岛素敏感性、胰岛素分泌、血糖及血脂的关联,发现4个AMPK基因的6组 largely 不重叠SNP分别与不同代谢性状相关,性状特异性遗传评分显示等位基因效应可叠加,其中体脂增加等位基因效应显著。

要点

  • AMPK基因变异对体脂、糖代谢和胆固醇代谢的遗传决定因素 largely 不重叠。
  • 体脂增加等位基因遗传评分每等位基因使BMI增加0.22 kg/m2(P=2.3×10-7)。
  • 胆固醇遗传评分每等位基因使总胆固醇和LDL胆固醇增加1.17 mg/dL。

核心结论

  • AMPK基因中 largely 不重叠的遗传决定因素分别与糖尿病/动脉粥样硬化相关性状相关,反映该酶控制的代谢通路。

研究设计与样本

  • 分析2789名非糖尿病参与者(来自Tübingen家族2型糖尿病研究),通过口服葡萄糖耐量试验进行代谢表征,并用全基因组SNP阵列进行基因分型。

主要发现

  • 在4个AMPK基因(PRKAA1、PRKAA2、PRKAG2、PRKAG3)中鉴定出6组 largely 不重叠的SNP,分别与肥胖、胰岛素敏感性、胰岛素分泌、血糖、总/LDL胆固醇或HDL胆固醇相关。
  • 体脂增加等位基因遗传评分每等位基因对BMI效应为+0.22 kg/m2(P=2.3×10-7),对胰岛素敏感性为-0.12×1019 L2/mol2(P=9.9×10-6),对2小时血糖为+0.02 mmol/L(P=0.0048)。
  • 降低胰岛素敏感性、降低胰岛素分泌和升高血糖的等位基因评分对血糖有类似效应。
  • 胆固醇遗传评分每等位基因使总胆固醇和LDL胆固醇增加1.17 mg/dL(P=0.0002和P=3.2×10-5),HDL遗传评分每等位基因使HDL胆固醇降低0.32 mg/dL(P=9.1×10-6)。

临床怎么用

  • 性状特异性遗传评分可反映AMPK通路相关代谢性状的等位基因叠加效应,体脂增加等位基因效应显著。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Adenosine monophosphate (AMP)-activated protein kinase (AMPK) is a heterotrimeric enzyme and central regulator of cellular energy metabolism. The impact of single nucleotide polymorphisms (SNPs) in all 7 AMPK subunit genes on adiposity, glucose metabolism, and lipid metabolism has not yet been systematically studied. OBJECTIVE: To analyze the associations of common SNPs in all AMPK genes, and of different scores thereof, with adiposity, insulin sensitivity, insulin secretion, blood glucose, low-density lipoprotein (LDL) cholesterol, high-density lipoprotein (HDL) cholesterol, total cholesterol, and triglycerides. STUDY DESIGN AND METHODS: A cohort of 2789 nondiabetic participants from the Tübingen Family study of type 2 diabetes, metabolically characterized by oral glucose tolerance test and genotyped by genome-wide SNP array, was analyzed. RESULTS: We identified 6 largely nonoverlapping SNP sets across 4 AMPK genes (PRKAA1, PRKAA2, PRKAG2, PRKAG3) associated with adiposity, insulin sensitivity, insulin secretion, blood glucose, total/LDL cholesterol, or HDL cholesterol, respectively. A genetic score of body-fat-increasing alleles revealed per-allele effect sizes on body mass index (BMI) of +0.22 kg/m2 (P = 2.3 × 10-7), insulin sensitivity of -0.12 × 1019 L2/mol2 (P = 9.9 × 10-6) and 2-hour blood glucose of +0.02 mmol/L (P = 0.0048). Similar effects on blood glucose were observed with scores of insulin-sensitivity-reducing, insulin-secretion-reducing and glucose-raising alleles, respectively. A genetic cholesterol score increased total and LDL cholesterol by 1.17 mg/dL per allele (P = 0.0002 and P = 3.2 × 10-5, respectively), and a genetic HDL score decreased HDL cholesterol by 0.32 mg/dL per allele (P = 9.1 × 10-6). CONCLUSIONS: We describe largely nonoverlapping genetic determinants in AMPK genes for diabetes-/atherosclerosis-related traits, which reflect the metabolic pathways controlled by the enzyme. Formation of trait-specific genetic scores revealed additivity of allele effects, with body-fat-raising alleles reaching a marked effect size. (J Clin Endocrinol Metab XX: 0-0, 2019).

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Randrianarisoa E, Lehn-Stefan A, Krier J, et al. AMPK Subunits Harbor Largely Nonoverlapping Genetic Determinants for Body Fat Mass, Glucose Metabolism, and Cholesterol Metabolism. J Clin Endocrinol Metab. 2020. PMID: 31512724. doi:10.1210/clinem/dgz020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。